The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2019

Filed:

Feb. 27, 2017
Applicants:

University of Kentucky Research Foundation, Lexington, KY (US);

University of Massachusetts, Worcester, MA (US);

Lund University, Malmö, SE;

Inventors:

B. Mark Evers, Lexington, KY (US);

Jing Li, Lexington, KY (US);

Paul Dobner, Worcester, MA (US);

Olle Melander, Malmö, SE;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); A61K 38/00 (2006.01); C12N 15/113 (2010.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); A61K 38/00 (2013.01); C12N 15/113 (2013.01); C12Q 1/6883 (2013.01); C12N 2310/14 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/912 (2013.01); G01N 2440/14 (2013.01); G01N 2800/50 (2013.01);
Abstract

The presently disclosed subject matter relates to a method for predicting increased risk of obesity on a non-obese subject. More particularly, the presently disclosed subject matter relates to a method of predicting increased risk of obesity in a non-obese subject by determining a level of neurotensin expression in a biological sample from the subject and comparing the level of neurotensin expression in the sample with a control level. The presently disclosed subject matter further relates to a method of preventing and/or treating obesity in a subject in need thereof by administering to the subject an effective amount of an agent that inhibits neurotensin.


Find Patent Forward Citations

Loading…